P. Launois

Type de document

Articles (10) Recensions (1)

Co-auteur

Date

Source

Mot-clé

infection (10) Infection (10) Leishmania (9) Mice (7) Leishmaniasis (7) parasite (5) maladie (5) Development (5) Cells (5) Animals (5) maladie (5) T cells (4) Patients (4) Human beings (4) Patients (4) Infections (4) virus (3) modèle (3) RNA (3) Parasites (3) Immune response (3) Expression (3) Example (3) Susceptibility (3) Parasites (3) résistance (3) puits (2) protéine (2) association (2) immunité (2)

Documents écrit par P. Launois (10) | parle de P. Launois (0)

Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.
M.A. Hartley et al. (2016)
MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden.
A. Ives et al. (2014)
Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model.
F. Tacchini-Cottier et al. (2012)
T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.
P. Launois et al. (2011)
Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.
A. Ives et al. (2011)
Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.
C. Ronet et al. (2010)
In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment.
E. Bourreau et al. (2009)
Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice.
C. Ronet et al. (2008)
Selective expression of the V beta 14 T cell receptor on Leishmania guyanensis--specific CD8+ T cells during human infection.
A. Kariminia et al. (2007)
Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope.
S. Pingel et al. (1999)